The Unstoppable Rise of GLP-1 Agonists: Revolutionising Diabetes and Obesity Treatment Over the past two years, the pharmaceutical industry has witnessed an unprecedented surge in the development and deployment of GLP-1 receptor agonists
WangDWanSLiuPMengFZhangXRenBet al
Future studies should explore these complex factors to develop more effective prevention and treatment strategies for better disease management goals
Scientists often study the blend to understand how peptides influence hormone release, interact with receptors, and affect metabolism
Mol Cell 14(3):395403 Latres E, Amini AR, Amini AA, Griffiths J, Martin FJ, Wei Y, Lin HC, Yancopoulos GD, Glass DJ (2005) Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway